{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:32:52Z","timestamp":1793377972163,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000724","name":"Health Foundation","doi-asserted-by":"publisher","award":["15-B-0234"],"award-info":[{"award-number":["15-B-0234"]}],"id":[{"id":"10.13039\/501100000724","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006356","name":"Syddansk Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006356","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031885","name":"N\u00e6stved, Slagelse og Ringsted Sygehuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031885","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.rmed.2026.109023","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T06:37:30Z","timestamp":1783751850000},"page":"109023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Beta-blockers and mortality after myocardial infarction in patients with and without chronic obstructive pulmonary disease \u2013 A Danish nationwide cohort study of 96,567 patients"],"prefix":"10.1016","volume":"261","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1213-9483","authenticated-orcid":false,"given":"Daniel B.","family":"Rasmussen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5994-8064","authenticated-orcid":false,"given":"Howraman","family":"Meteran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9827-440X","authenticated-orcid":false,"given":"Morten","family":"Lamberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Torp-Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Gislason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus T.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1231-9209","authenticated-orcid":false,"given":"Uffe","family":"Bodtger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2026.109023_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1164\/rccm.201201-0034OC","article-title":"Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease","volume":"186","author":"Divo","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2026.109023_bib2","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.amjcard.2006.09.112","article-title":"Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes","volume":"99","author":"Salisbury","year":"2007","journal-title":"Am. J. Cardiol."},{"issue":"38","key":"10.1016\/j.rmed.2026.109023_bib3","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.rmed.2026.109023_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/ehjqcco\/qcaa070","article-title":"Beta-blocker, aspirin and Statin usage after first-time myocardial infarction in patients with chronic obstructive pulmonary disease: a nationwide analysis from 1995 to 2015 in Denmark","volume":"6","author":"Rasmussen","year":"2020","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.rmed.2026.109023_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.114.001611","article-title":"\u0392-Blocker use and mortality in copd patients after myocardial infarction: a Swedish nationwide observational study","volume":"4","author":"Andell","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.rmed.2026.109023_bib6","first-page":"1","article-title":"Effect of \u03b2 blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records","volume":"347","author":"Quint","year":"2013","journal-title":"BMJ Online"},{"key":"10.1016\/j.rmed.2026.109023_bib7","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/thoraxjnl-2012-201945","article-title":"Association between \u03b2-blocker therapy and outcomes in patients hospitalised with acute exacerbations of chronic obstructive lung disease with underlying ischaemic heart disease, heart failure or hypertension","volume":"67","author":"Stefan","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2026.109023_bib8","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1093\/eurheartj\/ehaa793","article-title":"Association of \u03b2-blocker use with survival and pulmonary function in patients with chronic obstructive pulmonary and cardiovascular disease: a systematic review and meta-analysis","volume":"41","author":"Yang","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.rmed.2026.109023_bib9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ejhf.647","article-title":"Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the high-risk myocardi","volume":"19","author":"Coiro","year":"2016","journal-title":"Eur. J. Heart Fail."},{"issue":"5","key":"10.1016\/j.rmed.2026.109023_bib10","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.7535","article-title":"\u03b2-Blocker use and clinical outcomes in patients with COPD following acute myocardial infarction","volume":"7","author":"LaFon","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.rmed.2026.109023_bib11","article-title":"Early \u03b2-blocker use and in-hospital outcomes in patients with chronic obstructive pulmonary disease hospitalized with acute coronary syndrome: findings from the CCC-ACS project","volume":"11","author":"Zhang","year":"2024","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.rmed.2026.109023_bib12","first-page":"148","article-title":"Methods for time-varying exposure related problems in pharmacoepidemiology: an overview. Pharmacoepidemiol","volume":"27","author":"Pazzagli","year":"2018","journal-title":"Drug Saf."},{"key":"10.1016\/j.rmed.2026.109023_bib13","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ahj.2015.03.019","article-title":"Persistence with secondary prevention medications after acute myocardial infarction: insights from the TRANSLATE-ACS study","volume":"170","author":"Mathews","year":"2015","journal-title":"Am. Heart J."},{"issue":"15","key":"10.1016\/j.rmed.2026.109023_bib14","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJMoa2401479","article-title":"Beta-blockers after myocardial infarction and preserved ejection fraction","volume":"390","author":"Yndigegn","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.rmed.2026.109023_bib15","doi-asserted-by":"crossref","first-page":"6744","DOI":"10.3390\/jcm13226744","article-title":"Comparison of outcomes between ST-Segment elevation and Non-ST-Segment elevation myocardial infarctions based on left ventricular ejection fraction","volume":"13","author":"Kim","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.rmed.2026.109023_bib16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.rmed.2026.109023_bib17","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish civil registration system as a tool in epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.rmed.2026.109023_bib18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1403494811399958","article-title":"The Danish register of causes of death","volume":"39","author":"Helweg-Larsen","year":"2011","journal-title":"Scand. J. Publ. Health"},{"key":"10.1016\/j.rmed.2026.109023_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/1403494811405098","article-title":"Danish registers on personal income and transfer payments","volume":"39","author":"Baadsgaard","year":"2011","journal-title":"Scand. J. Publ. Health"},{"key":"10.1016\/j.rmed.2026.109023_bib20","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2147\/CLEP.S99489","article-title":"Danish register of chronic obstructive pulmonary disease","volume":"8","author":"Lange","year":"2016","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.rmed.2026.109023_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012832","article-title":"Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study","volume":"6","author":"Sundb\u00f8ll","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.rmed.2026.109023_bib22","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.amjcard.2011.06.003","article-title":"Long-term prognosis of first myocardial infarction according to the electrocardiographic pattern (st elevation myocardial infarction, non-st elevation myocardial infarction and non-classified myocardial infarction) and revascularization procedures","volume":"108","author":"Garc\u00eda-Garc\u00eda","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.rmed.2026.109023_bib28","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2147\/CLEP.S147175","article-title":"Conditioning on future exposure to define study cohorts can induce bias: the case of low-dose acetylsalicylic acid and risk of major bleeding","volume":"9","author":"Lund","year":"2017","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.rmed.2026.109023_bib23","doi-asserted-by":"crossref","first-page":"690","DOI":"10.7326\/M13-1581","article-title":"Relation of nonsteroidal anti-inflammatory drugs to serious bleeding and thromboembolism risk in patients with atrial fibrillation receiving antithrombotic therapy","volume":"161","author":"Lamberts","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.rmed.2026.109023_bib24","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.rmed.2011.01.012","article-title":"Validity and underrecording of diagnosis of COPD in the Danish National Patient Registry","volume":"105","author":"Thomsen","year":"2011","journal-title":"Respir. Med."},{"issue":"4","key":"10.1016\/j.rmed.2026.109023_bib25","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/resp.14486","article-title":"Global initiative for chronic obstructive lung disease 2023 report: GOLD Executive summary","volume":"28","author":"Agust\u00ed","year":"2023","journal-title":"Respirology"},{"key":"10.1016\/j.rmed.2026.109023_bib26","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"Hurst","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2026.109023_bib27","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.rmed.2015.10.015","article-title":"Medically treated exacerbations in COPD by GOLD 1-4: a valid, robust, and seemingly low-biased definition","volume":"109","author":"Ingebrigtsen","year":"2015","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2026.109023_bib29","first-page":"1887","article-title":"Robust causal inference using directed acyclic graphs: the R package \u201cdagitty.\u201d","volume":"45","author":"Textor","year":"2016","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.rmed.2026.109023_bib30","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.amjmed.2014.05.032","article-title":"Clinical outcomes with \u03b2-blockers for myocardial infarction: a meta-analysis of randomized trials","volume":"127","author":"Bangalore","year":"2014","journal-title":"Am. J. Med."},{"key":"10.1016\/j.rmed.2026.109023_bib31","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.jacc.2014.03.014","article-title":"Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the Metocard-CNIC trial (Effect of metoprolol in cardioprotection during an acute myocardial infarction)","volume":"63","author":"Pizarro","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.rmed.2026.109023_bib33","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1016\/j.jacc.2017.03.578","article-title":"\u03b2-Blockers and mortality after acute myocardial infarction in patients without heart failure or ventricular dysfunction","volume":"69","author":"Dondo","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.rmed.2026.109023_bib34","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/1074248415608011","article-title":"Does oral beta-blocker therapy improve long-term survival in ST-Segment elevation myocardial infarction with preserved systolic function? A meta-analysis","volume":"21","author":"Misumida","year":"2015","journal-title":"J. Cardiovasc. Pharmacol. Therapeut."},{"key":"10.1016\/j.rmed.2026.109023_bib35","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.2147\/COPD.S145913","article-title":"Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD","volume":"12","author":"Huang","year":"2017","journal-title":"Int. J. COPD"},{"key":"10.1016\/j.rmed.2026.109023_bib36","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehaa1058","article-title":"Effect of long-term beta-blocker treatment following myocardial infarction among stable, optimally treated patients without heart failure in the reperfusion era: a Danish, nationwide cohort study","author":"Holt","year":"2021","journal-title":"Eur. Heart J."},{"issue":"24","key":"10.1016\/j.rmed.2026.109023_bib37","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1056\/NEJMoa1908142","article-title":"Metoprolol for the prevention of acute exacerbations of COPD","volume":"381","author":"Dransfield","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.rmed.2026.109023_bib38","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jama.2024.8771","article-title":"Bisoprolol in patients with chronic obstructive pulmonary disease at high risk of exacerbation: the BICS randomized clinical trial","volume":"332","author":"Devereux","year":"2024","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.rmed.2026.109023_bib39","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1136\/thoraxjnl-2019-214206","article-title":"Beta-blocker use and acute exacerbations of COPD following myocardial infarction: a Danish nationwide cohort study","volume":"75","author":"Rasmussen","year":"2020","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2026.109023_bib40","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s11606-010-1609-1","article-title":"Healthy user and related biases in observational studies of preventive interventions : a primer for physicians","volume":"26","author":"Shrank","year":"2011","journal-title":"J. Gen. Intern. Med."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126003914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126003914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:37:35Z","timestamp":1793374655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611126003914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":39,"alternative-id":["S0954611126003914"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2026.109023","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beta-blockers and mortality after myocardial infarction in patients with and without chronic obstructive pulmonary disease \u2013 A Danish nationwide cohort study of 96,567 patients","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2026.109023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109023"}}